Journal of chemotherapy (Florence, Italy)
Integrating immunotherapy into chemotherapy: real-world efficacy of GEMOX plus Tislelizumab in advanced gallbladder cancer.
Daming Zhang, Yuchuan Liang, Jinbo Yang, Aihua Pei, Jianlong Xu, Yue Zhao
Published: 202510.1080/1120009X.2025.2568807
Abstract
This study aimed to evaluate the efficacy and prognostic factors of GEMOX (gemcitabine and oxaliplatin) combined with Tislelizumab in patients with advanced Gallbladder cancer (GBC). 150 patients with stage III-IV GBC were divided into two groups: 88…
Preview only. Read the full abstract at the source